跳至主要内容
临床试验/NCT05078229
NCT05078229已完成不适用

Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers

H. Lee Moffitt Cancer Center and Research Institute1 个研究点 分布在 1 个国家目标入组 505 人开始时间: 2021年9月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
505
试验地点
1
主要终点
Patient Distress at 6 Month Follow-up (CESD)

研究概览

简要总结

The purpose of the study is to understand whether different stress management interventions impact stress among HCT cancer caregivers and patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Caregiver Inclusion Criteria:
  • Caring for a patient planning to receive an allogeneic HCT at Moffitt
  • Intending to remain primary caregiver throughout patient treatment (i.e., will be the caregiver the majority of the time)
  • Able to provide informed consent
  • Able to read and write in English
  • Owns a smartphone and is willing to download the study app
  • Patient Inclusion Criteria:
  • Receiving an allogeneic HCT at the cancer center
  • Able to provide informed consent
  • Able to read and write in English

排除标准

  • Under 21 years of age
  • Unable to provide informed consent
  • Unable to read and write in English
  • Caregiver is unable to remain primary caregiver throughout patient treatment
  • Patient does not receive transplant at Moffitt Cancer Center

研究组 & 干预措施

Healthy Living

Active Comparator

Healthy Living (HL) will consist of six, 45-60 minute sessions delivered one-on-one; sessions 1-3 in-person on HCT unit and sessions 4-6 via video conference. HL will be based on the American Cancer Society's (ACS) Caregiver Resource Guide.

干预措施: Healthy Living (Behavioral)

Standard of Care - Enhanced Care

No Intervention

Participants in Enhanced Care will receive treatment consistent with what is offered to all caregivers of allogeneic HCT patients. This entails the option of attending weekly support groups and meeting with social workers as needed. At the baseline session, participants randomized to Enhanced Care will be provided with a modified version of the ACS Caregiver Resource Guide.

FOCUS

Experimental

Focusing On mindfulness for Caregivers Under Stress (FOCUS)will consist of six one-on-one, 45-60 minute sessions delivered either in-person (sessions 1-3) or via video conference (sessions 4-6). The first few sessions will primarily focus on how to direct attention to the breath or some object of attention (e.g., parts of the body). As the program progresses, participants are asked to apply these skills to thoughts and emotions. Throughout the treatment, caregivers are reminded to utilize existing coping skills, as well as how to integrate the new skills learned throughout this program for managing stress. Formal mindfulness meditations are conducted within each session, lasting from 7-20 minutes; participants will be asked to practice mindfulness exercises daily.

干预措施: FOCUS (Behavioral)

结局指标

主要结局

Patient Distress at 6 Month Follow-up (CESD)

时间窗: 6 Month Follow-up after end of treatment

Patient distress will be measured using the Center for Epidemiological Studies Depression Scale (CESD). The CESD is comprised of 20 4-point Likert scale items and has been commonly used among cancer caregivers. Participants rate how often over the past week they experienced symptoms associated with depression, such as restless sleep, poor appetite, and feeling lonely. Response options range from 0 to 3 for each item (0 = Rarely or None of the Time, 1 = Some or Little of the Time, 2 = Moderately or Much of the time, 3 = Most or Almost All the Time). Scores range from 0 to 60, with high scores indicating greater depressive symptoms.

Patient Distress at 6 Month Follow-up (GAD-7)

时间窗: 6 Month Follow-up after end of treatment

Patient distress will be measured using the Generalized Anxiety Disorder-7 (GAD-7). The GAD-7 is comprised of 8 items on a 4-point Likert scale and has been used extensively among cancer caregivers. Participants rate the severity of his or her symptoms over the past two weeks. The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of "not at all," "several days," "more than half the days," and "nearly every day," respectively, and then adding together the scores for the seven questions

Caregiver Burden at 2 Month Follow-up

时间窗: 2 month follow up after end of treatment

Caregiver burden will be measured using the Zarit Burden Interview Short Form (ZBI). The ZBI is 12 items using a 5-point Likert scale assessing caregiver burden. Participants rate burden on a scale of 0 to 4, 0 indicating "rarely" an issue and 4 indicating "nearly always". The ZBI has been validated in populations of cancer caregivers and has demonstrated very good internal consistency and discriminative ability

Patient Distress at 2 Month Follow-up (CESD)

时间窗: 2 Month Follow-up after end of treatment

Patient distress will be measured using the Center for Epidemiological Studies Depression Scale (CESD). The CESD is comprised of 20 4-point Likert scale items and has been commonly used among cancer caregivers. Participants rate how often over the past week they experienced symptoms associated with depression, such as restless sleep, poor appetite, and feeling lonely. Response options range from 0 to 3 for each item (0 = Rarely or None of the Time, 1 = Some or Little of the Time, 2 = Moderately or Much of the time, 3 = Most or Almost All the Time). Scores range from 0 to 60, with high scores indicating greater depressive symptoms.

Caregiver Burden at End of Treatment

时间窗: Up to 8 Weeks

Caregiver burden will be measured using the Zarit Burden Interview Short Form (ZBI). The ZBI is 12 items using a 5-point Likert scale assessing caregiver burden. Participants rate burden on a scale of 0 to 4, 0 indicating "rarely" an issue and 4 indicating "nearly always" The ZBI has been validated in populations of cancer caregivers and has demonstrated very good internal consistency and discriminative ability

Caregiver Burden at 6 Month Follow-up

时间窗: 6 month follow up after end of treatment

Caregiver burden will be measured using the Zarit Burden Interview Short Form (ZBI). The ZBI is 12 items using a 5-point Likert scale assessing caregiver burden. Participants rate burden on a scale of 0 to 4, 0 indicating "rarely" an issue and 4 indicating "nearly always". The ZBI has been validated in populations of cancer caregivers and has demonstrated very good internal consistency and discriminative ability

Patient Distress at End of Treatment (CESD)

时间窗: Up to 8 Weeks

Patient distress will be measured using the Center for Epidemiological Studies Depression Scale (CESD). The CESD is comprised of 20 4-point Likert scale items and has been commonly used among cancer caregivers. Participants rate how often over the past week they experienced symptoms associated with depression, such as restless sleep, poor appetite, and feeling lonely. Response options range from 0 to 3 for each item (0 = Rarely or None of the Time, 1 = Some or Little of the Time, 2 = Moderately or Much of the time, 3 = Most or Almost All the Time). Scores range from 0 to 60, with high scores indicating greater depressive symptoms.

Patient Distress at End of Treatment (GAD-7)

时间窗: Up to 8 Weeks

Patient distress will be measured using the Generalized Anxiety Disorder-7 (GAD-7). The GAD-7 is comprised of 8 items on a 4-point Likert scale and has been used extensively among cancer caregivers. Participants rate the severity of his or her symptoms over the past two weeks. The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of "not at all," "several days," "more than half the days," and "nearly every day," respectively, and then adding together the scores for the seven questions

Patient Distress at 2 Month Follow-up (GAD-7)

时间窗: 2 Month Follow-up after end of treatment

Patient distress will be measured using the Generalized Anxiety Disorder-7 (GAD-7). The GAD-7 is comprised of 8 items on a 4-point Likert scale and has been used extensively among cancer caregivers. Participants rate the severity of his or her symptoms over the past two weeks. The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of "not at all," "several days," "more than half the days," and "nearly every day," respectively, and then adding together the scores for the seven questions

次要结局

  • Patient Healthcare Utilization - unexpected clinic visits post discharge at 6 Month Follow-up(6 Month Follow-up after end of treatment)
  • Patient Healthcare Utilization - Readmissions to the hospital at 6 Month Follow-up(6 Month Follow-up after end of treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验